mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.004 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.004 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |